Are Surgeons Collecting Enough Tumor Tissue in Laparoscopic Biopsies for HRD Testing?

Recorded Live: June 16, 2022.

Description

Recorded Live: June 16, 2022

Speaker & Presentation Information

Moderator:
Tom Herzog, MD

Panelists:
Sharyn N. Lewin, MD
Gulisa Turashvili, MD, PhD
Shannon N. Westin, MD, MPH

Supported in part by

Summary

Availability:

On-Demand

Cost:

FREE

Create Account

Recommended

Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications

This course offers an in-depth exploration of personalized treatment approaches for endometrial cancers, focusing on proficient mismatch repair (pMMR), deficient mismatch repair (dMMR) diseases and molecular classification in the recurrent setting.

FREE

IGCS 2024 Endometrial Cancer Master Session

Held at the IGCS 2024 Annual Global Meeting in Dublin, Ireland on October 16, 2024.

FREE

Palliative Care Certificate Program (2023 Update)

The palliative care curriculum introduces the practicing health care provider to the knowledge and skills necessary to provide palliative interventions for patients suffering associated with women’s cancer.

FREE

Journal Club: The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial

Listen to a new Journal Club with lead author Dr. Angeles Alvarez Secord and moderator Dr. Robert Coleman as they discuss details on the recently published article The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial.

FREE

IGCS 2024 Cervical Master Sessions: Moving Forwards

Held at the IGCS 2024 Annual Global Meeting in Dublin, Ireland on October 16, 2024.

FREE

From Data to Practice: Integrating Key Phase III Results into Ovarian Cancer Management

Kathleen Moore details outcome measures from three major phase III trials—KEYNOTE-B96, ROSELLA, and MIRASOL—highlighting objective response rates, progression-free and overall survival, and key safety signals.

FREE

Redefining Platinum Sensitivity : Additional Treatment Considerations in a Changing Paradigm

Dr. Robert Coleman with moderation by Dr. Floor Backes and Dr. Wendel Naumman. Dr. Coleman explores the evolving treatment strategies for recurrent platinum-sensitive ovarian cancer, drawing on the latest clinical trial data and real-world outcomes.

FREE

IGCS 2024 Ovarian Master Sessions: The Era of Targeted Therapies

FREE

Surgical Film Library

Curated film collection reviewed by global surgical experts showcasing gynecologic oncology surgery procedures and techniques. Films provide practical learning through surgical demonstrations.

FREE

Patient reported outcomes exploring quality of life in PROC and novel therapeutics: mirvetuximab in recurrent ovarian cancer

Discover how patient-reported outcomes highlight mirvetuximab’s ability to preserve quality of life while delivering meaningful clinical benefits for women with platinum-resistant ovarian cancer.

FREE